Patent Assignment
Reel/Frame 068810/0460
Release of Security Interest
Recorded: 2024-10-07
Pages: 8
Assignor
ACQUIOM AGENCY SERVICES LLC
Executed: 2024-09-26
Assignees
MALLINCKRODT ENTERPRISES LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT LLC
385 MARSHALL AVENUE, WEBSTER GROVES, MISSOURI, 63119
SPECGX LLC
385 MARSHALL AVENUE, WEBSTER GROVES, MISSOURI, 63119
OCERA THERAPEUTICS, INC.
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
STRATATECH CORPORATION
510 CHARMANY DR. NO. 169, MADISON, WISCONSIN, 53719
VTESSE LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN, DUBLIN, 15, IRELAND
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN, DUBLIN, IRELAND
SUCAMPO PHARMA AMERICAS LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 64042
Covered Properties
(20)
L-Ornithine Phenyl Acetate and Methods of Making Thereof
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Methods of Making L-Ornithine Phenyl Acetate
L-Ornithine Phenyl Acetate and Methods of Making Thereof
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Methods of Making L-Ornithine Phenyl Acetate
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Formulations of L-Ornithine Phenylacetate
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Treatment and Prevention of Muscle Loss Using L-Ornithine in Combination with at Least One of Phenylacetate and Phenylbutyrate
Treatment of Portal Hypertension and Restoration of Liver Function Using L-Ornithine Phenylacetate
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Processes of Making L-Ornithine Phenylacetate
L-Ornithine Phenyl Acetate and Methods of Making Thereof
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Formulations of L-Ornithine Phenylacetate
Application:
17/559,453 →
Publication:
US 2022/0184014
Formulations of L-Ornithine Phenylacetate
Application:
17/570,253 →
Publication:
US 2022/0202755
Methods of Assessing Hepatic Encephalopathy
Dosages and Uses of Ornithine Phenylacetate for Treating Hyperammonemia
Application:
17/767,009 →
Publication:
US 2022/0362192
Uses of Ornithine Phenylacetate for Treating Hyperammonemia
Application:
17/926,978 →
Publication:
US 2023/0201148
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 12, 2017
From: DOUGAN, CHRISTINE HENDERSON; WATT, STEPHEN WILLIAM
To: SOLID FORM SOLUTIONS LTD.
Reel/Frame 040955/0956 →
Assignment of Assignor's Interest
Jan 12, 2017
From: ANDERSON, KEITH; BEHLING, JIM; DOUGAN, CHRISTINE HENDERSON; WATT, STEPHEN WILLIAM
To: OCERA THERAPEUTICS, INC.
Reel/Frame 040960/0233 →
Assignment of Assignor's Interest
Jan 12, 2017
From: HELSINN ADVANCED SYNTHESIS SA
To: OCERA THERAPEUTICS, INC.
Reel/Frame 041349/0531 →
Assignment of Assignor's Interest
Jan 12, 2017
From: MANINI, PETER; FIGINI, ATTILIA
To: HELSINN ADVANCED SYNTHESIS SA
Reel/Frame 040955/0486 →
Assignment of Assignor's Interest
Jan 12, 2017
From: SOLID FORM SOLUTIONS LTD.
To: OCERA THERAPEUTICS, INC.
Reel/Frame 040956/0024 →
Assignment of Assignor's Interest
Jan 26, 2017
From: SOLID FORM SOLUTIONS LTD.
To: OCERA THERAPEUTICS, INC.
Reel/Frame 041098/0073 →
Assignment of Assignor's Interest
Jan 26, 2017
From: WATT, STEPHEN WILLIAM
To: SOLID FORM SOLUTIONS LTD.
Reel/Frame 041098/0043 →
Assignment of Assignor's Interest
Jan 26, 2017
From: HELSINN ADVANCED SYNTHESIS SA
To: OCERA THERAPEUTICS, INC.
Reel/Frame 041098/0001 →
Assignment of Assignor's Interest
Jan 26, 2017
From: MANINI, PETER; FIGINI, ATTILIA
To: HELSINN ADVANCED SYNTHESIS SA
Reel/Frame 041097/0984 →
Assignment of Assignor's Interest
Jan 26, 2017
From: ANDERSON, KEITH; BEHLING, JIM
To: OCERA THERAPEUTICS, INC.
Reel/Frame 041098/0038 →
Terms and Conditions of Employment
Jan 26, 2017
From: DOUGAN, CHRISTINE
To: SOLID FORM SOLUTIONS LIMITED
Reel/Frame 041513/0173 →
Notice of Grant of Security Interest in Intellectual Property
Dec 22, 2017
From: OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 044949/0634 →
Assignment of Assignor's Interest
May 15, 2018
From: ROSE, CHRISTOPHER F.; ROUSSEAU, FRANCK
To: OCERA THERAPEUTICS, INC.
Reel/Frame 045813/0066 →
Assignment of Assignor's Interest
Nov 30, 2018
From: ANDERSON, KEITH
To: OCERA THERAPEUTICS, INC.
Reel/Frame 047643/0211 →
Assignment of Assignor's Interest
Nov 30, 2018
From: JALAN, RAJIV
To: UCL BUSINESS PLC
Reel/Frame 047643/0444 →
Notice of Grant of Security Interest in Intellectual Property
Jul 22, 2019
From: OCERA THERAPEUTICS
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 049823/0220 →
Assignment of Assignor's Interest
Sep 20, 2019
From: MANINI, PETER; FIGINI, ATTILIA
To: HELSINN ADVANCED SYNTHESIS SA
Reel/Frame 050449/0049 →
Assignment of Assignor's Interest
Sep 20, 2019
From: HELSINN ADVANCED SYNTHESIS SA
To: OCERA THERAPEUTICS, INC. C/O MALLINCKRODT PHARMACEUTICALS
Reel/Frame 050452/0709 →
Assignment of Assignor's Interest
Sep 20, 2019
From: WATT, STEPHEN WILLIAM; DOUGAN, CHRISTINE HENDERSON
To: SOLID FORM SOLUTIONS LTD.
Reel/Frame 050449/0015 →
Assignment of Assignor's Interest
Sep 23, 2019
From: SOLID FORM SOLUTIONS LTD.
To: OCERA THERAPEUTICS, INC. C/O MALLINCKRODT PHARMACEUTICALS
Reel/Frame 050455/0320 →
Assignment of Assignor's Interest
Sep 23, 2019
From: ANDERSON, KEITH; BEHLING, JIM
To: OCERA THERAPEUTICS, INC. C/O MALLINCKRODT PHARMACEUTICALS
Reel/Frame 050455/0270 →
Change of Name
Nov 27, 2019
From: UCL BUSINESS PLC
To: UCL BUSINESS LTD
Reel/Frame 051144/0324 →
Notice of Grant of Security Interest in Intellectual Property
Dec 9, 2019
From: MALLINCKRODT LLC; OCERA THERAPEUTICS, INC.; MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 051231/0961 →
Security Interest
Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Notice of Grant of Security Interest in Intellectual Property
Apr 21, 2020
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 052456/0158 →